| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.25 | 0.001 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |